Received some incredibly difficult news. Histology from my brain surgery confirmed my tumour is a malignant, terminal grade 4 glioblastoma. Moving forward with chemo/radiotherapy to buy time, but focus is on quality of life. Devastated. Please hold your loved ones tight. ❤️
Congratulations to all - especially to Irish representatives @HennessyMaeve and @rachelkeogh...delighted for you
We're thrilled to officially announce the 2026 class of Conquer Cancer Grants and Awards recipients! 🔬 These grants empower the next generation of physician-scientists to turn innovative ideas into clinical breakthroughs. Congratulations to the new class—see you in Chicago for #ASCO26!
Full list of recipients here: bit.ly/4x0qpBF
#ResearchConquersCancer #ConquerCancer @ASCO
1
13
294
David O Reilly retweeted
Congratulations to Dr @OanaDeac , NCRI intern, Oncology Specialist Registrar and ICAT Fellow , on her open‑access publication on young‑onset GI cancer.
🔬 Linking clinical expertise with population cancer data for real‑world insights.
🔗 authors.elsevier.com/sd/arti…
David O Reilly retweeted
Delighted to see our data on 1st line zongertinib in HER2 TKD mutant NSCLC pts with and without CNS mets (BEAMION-Lung01), now in @NEJM. Now FDA approved 1st line. Hoping for @MHRAgovuk & @NICEComms approvals to follow! @royalmarsdenNHS @ICR_London
In a phase 1 trial of first-line zongertinib for HER2-mutated non–small-cell lung cancer, an objective response occurred in 76% of patients, with a median progression-free survival of 14.4 months. Full Beamion LUNG-1 trial results: nejm.org/doi/full/10.1056/NE…
Editorial: EGFR’s Poor Sibling nejm.org/doi/full/10.1056/NE…
Super interesting KRAS session - congrats @DrJNaidoo @DocSacher
KANDELELIT-001: Striking activity in PDL1>50% with RR of 87%
ADEPPT: Durable responses seen in subset of patients
@etop_ibcsg @CancerCentreIre @cancertrials_ie
6
133
Congrats @mraheelhashim and @FordePatrick. Thought provoking study - expect to see lots of studies more like this soon!
🚨🚨
Hot off the press
How Much Is Enough? Ultra-Low Doses of Immunotherapy to Improve Access and Affordability
@JCO_ASCO editorial on IO dosing
In view of recent debate regarding ultra low doses of Nivolumab
ascopubs.org/doi/10.1200/JCO…
5
160
David O Reilly retweeted
National trends in Early Onset Colorectal Cancer: Incidence and Challenges in the Republic of Ireland.
Read the full article. brnw.ch/21x03ax
#ColorectalCancer
David O Reilly retweeted
Pleased to publish the Ph II ARC-10 trial: Domvanalimab (Fc-silent TIGIT)+zimberelimab (PD-1) in PDL1≥50% NSCLC:
- 95pts
- mPFS HR 0.69; mOS HR 0.64
- g3+ TRAEs 21% v 15%
Study stopped early→alas, TIGIT+PD-1
@OncoAlert @CancerCentreIre #LCSM
lungcancerjournal.info/artic…
Congratulations @CanResUCC for this exciting time for the South of Ireland @RoisinMConnolly @jgleesonirl @Seamusoreilly18 @Dcollinsflynn
Inspiring day @CanResUCC @UCC World Cancer Day Event. Super lineup outlining cancer trial innovations
- Liquid biopsy @DrSanjayPopat
- Investigator-led trials @jgleesonirl
- Working with @cancertrials_ie @gerryhanna
Congrats @RoisinMConnolly on a dynamic & ambitious vision
6
207
Big thanks to supervisors, examiners and chair and many more for all their help getting this far! @DrJNaidoo @sinead_toomey Bryan Hennessy, Judith Coppinger @DrSanjayPopat @MariOzaki14 @RCSI_Irl @CancerCentreIre
Huge congratulations to Dr @DavidOReilly2 who successfully defended his PhD thesis this morning. Thanks to Prof @DrSanjayPopat and Prof Judith Coppinger for examining, Dr @MariOzaki14 for chairing and @RCSI_postgrad for all the support
5
20
325
Very proud of Prof. @DrJNaidoo ! Idly reading emails from week & came across below from Hopkins where she is adjunct faculty. Not a surprise but she is one of the most highly cited scientists worldwide & we are lucky she is leading lung cancer research @RCSI_Irl @CancerCentreIre
1
10
293
David O Reilly retweeted
Implementation of the SIPS surgical handover system was associated with improvements in handover quality, patient physiology, and staff perceptions of safety without prolonging handover meetings. ja.ma/4gUFL2O
bmjopenrespres.bmj.com/conte…
Pleased to share our protocol for the Lung Health Check published in @BMJOpen_Resp discussing the approach of a community-based lung cancer screenimg programme @CancerCentreIre @DrJNaidoo @IrishCancerSoc @lung_check_ie
David O Reilly retweeted
David O Reilly retweeted
#TeamIrelandWCLC25☘️
Ireland’s lung cancer team at #WCLC25 — nurses, surgeons, oncologists, scientists & advocates, working for patients
@IASLC @CancerCentreIre @CancerInstIRE @UL @CanResUCC @svuh @MaterCancer @uniofgalway @QUBelfast @TUH_Tallaght @LungCommunity @IrishCancerSoc
Lots of interest in how to incorporate EBC into liquid biopsy translational and clinical pathways. Thanks @IASLC for oppurtunity to present!
@IrishCancerSoc @CancerCentreIre @CancerInstIRE @DrJNaidoo @sinead_toomey @RCSI_Irl @Drogheda_Oncol
Such an important patient-centered talk from Ornagh reminding us of the most important things. Congrats Ornagh! @CancerCentreIre @IASLC @DrJNaidoo @LungCommunity #WCLC25
Congrats to poster presenters today!
- Survival outcomes in female never smokers with NSCLC @zaccoyne
- T Cell charecteristics in early stage NSCLC @laurastaunton
-Radiation oncology clinical trial eligibility in real world cohort @gwalls89
Congratulations @DrJNaidoo ! How lucky we are to have an Irish co-chair of the world lung cancer conference #WCLC25 @cancertrials_ie @CancerCentreIre
Great #WCLC25 opening Ceremony with the amazing chairs @UmbertoMalapel1 @DrJNaidoo @NReguart @IsaOpitz !! Congrats on the success of this excellent meeting!
@IASLC










































